๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatic stellate cells: a target for the treatment of liver fibrosis

โœ Scribed by Jian Wu; Mark A. Zern

Publisher
Springer Japan
Year
2000
Tongue
English
Weight
93 KB
Volume
35
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hepatic stellate cells as a target for T
Hepatic stellate cells as a target for TZD: Can we treat liver fibrosis and type II diabetes at the same time?
โœ Hide Tsukamoto ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB

Background & Aims: The ligand-dependent transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed in hepatic stellate cells (HSC), and its transcriptional activity is reduced during cell transdifferentiation in culture. PPARgamma transcriptional activation decrea

Phagocytosis of apoptotic bodies by hepa
Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo
โœ Shan-Shan Zhan; Joy X. Jiang; Jian Wu; Charles Halsted; Scott L. Friedman; Mark ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 923 KB

Hepatic stellate cell activation is a main feature of liver fibrogenesis. We have previously shown that phagocytosis of apoptotic bodies by stellate cells induces procollagen โฃ1 (I) and transforming growth factor beta (TGF-โค) expression in vitro. Here we have further investigated the downstream effe